<ul><li>Isomorphic Labs, an AI drug development startup founded by Google DeepMind CEO Demis Hassabis, has raised $600 million in its first external funding round. The startup aims to revolutionize and accelerate drug discovery using advanced AI models, with a focus on finding a cure for all diseases.</li><li>The funding round was led by Thrive Capital, with participation from GV and follow-on investment from Alphabet. Isomorphic Labs' proprietary AI platform, which includes breakthroughs like AlphaFold 3, accurately predicts the structure and interaction of biological molecules.</li><li>Agility Robotics, the creator of humanoid robot Digit, is raising $400 million in new funding. The Oregon State University spinout aims to fill vacant positions in material handling across industries with its robots-as-a-service plan.</li><li>Temporal Technologies, a software startup, has raised $146 million in a Series C round. The funding will be used to speed up product development for the Temporal Cloud managed service and expand the reach of Temporal's durable execution platform into AI use cases.</li></ul>

AI Startups: Google DeepMind CEO’s Startup Raises $600 Million

Discover more